Aridis Pharmaceuticals, Inc. Skyrocketed

Fri, Jul 29, 2022 at 06:58 PM
Aridis Pharmaceuticals, Inc. Skyrocketed

Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) jumped higher at $2.47, representing a gain of 28.6%. On Fri, Jul 29, 2022, ARDS:NASDAQ hit a New 2-Week High of $2.47. The stock appeared on our News Catalysts scanner on Fri, Jul 01, 2022 at 02:18 PM in the 'BIOTECH' category. From Fri, Jul 15, 2022, the stock recorded 80.00% Up Days and 45.45% Green Days

The stock spiked on Thu, Feb 17, 2022 at $2.94 with a volume of 3M+.

About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.